| Literature DB >> 26375218 |
Mary S Matsui1, Sérgio Schalka2, Garrett Vanderover1, Christina G Fthenakis1, J Christopher1, Patricia Camarano Pinto Bombarda2, Juliana Regina Bueno2, Bianca Lenci Inácio Viscomi2, Mário Sérgio Bombarda Júnior2.
Abstract
BACKGROUND: Peri-orbital dark circles are a cosmetic concern worldwide, and have been attributed to hyperpigmentation from allergy or atopic dermatitis, blood stasis, structural shadowing effects, and a thin epidermis/dermis under the eye. It is of interest to better understand lifestyle and demographic risk factors and the relative impact of melanin, blood and epidermal/dermal factors on the severity of Peri-orbital dark circles.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26375218 PMCID: PMC4560538 DOI: 10.1590/abd1806-4841.20153520
Source DB: PubMed Journal: An Bras Dermatol ISSN: 0365-0596 Impact factor: 1.896
Distribution of DUEC severity - general and according to the age group
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
|
| 483 | 22 (4,6) | 154 (31,9) | 107 (22,2) | 125 (25,9) | 75 (15,6) |
|
| ||||||
| 10-19 | 22 | 0 (0) | 10 (45) | 7 (32) | 4 (18) | 1 (5) |
| 20-29 | 115 | 8 (7) | 39 (34) | 27 (23) | 27 (23) | 14 (12) |
| 30-39 | 150 | 7 (5) | 52 (35) | 28 (19) | 40 (27) | 23 (15) |
| 40-49 | 117 | 1 (1) | 35 (30) | 26 (22) | 35 (30) | 20 (17) |
| 50+ | 75 | 6 (8) | 17 (23) | 18 (24) | 18 (24) | 16 (21) |
DUEC 1 = absent; 2 = mild; 3 = mild/moderate; 4 = moderate; 5 = severe
FIGURE 1Distribution of Fitzpatrick skin types of all subjects
Age of onset and DUEC severity
|
|
|
|
|
| ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| ||||
| 10-19 | 109 | 4 | 24 | 25 | 27 | 29 | ||
| 3.7% | 22% | 22.9% | 24.8% | 26.6% | ||||
| 20-29 | 94 | 1 | 29 | 18 | 29 | 17 | 0.020 | |
| 1.1% | 30.9% | 19.1% | 30.9% | 18.1% | ||||
| Age of onset among "yes" in self-assessment; | 30-39 | 77 | 0 | 32 | 19 | 20 | 5 | |
| Age < 10 excluded | 0% | 41.6% | 24.7% | 26% | 6.5% | |||
| 40-49 | 30 | 2 | 11 | 7 | 6 | 4 | ||
| 6.7% | 36.7% | 23.3% | 20% | 13.3% | ||||
| 50+ | 3 | 0 | 1 | 0 | 1 | 0 | ||
| 0% | 50% | 0% | 50% | 0 | ||||
The red values indicate the "center" of the data (median)
significant at p<0,05
Allergy history and DUEC
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| |||||
| Asthma | Self | 10 | 0 | 2 | 1 | 4 | 3 | ||
| 0% | 20% | 10% | 40% | 30% | |||||
| Relatives | 42 | 1 | 22 | 10 | 6 | 3 | 0.010 | ||
| 2.4% | 52.4% | 23.8% | 14.3% | 7.1% | |||||
| Both | 3 | 0 | 3 | 0 | 0 | 0 | |||
| 0% | 100% | 0% | 0% | 0% | |||||
| Neither | 442 | 21 | 125 | 92 | 112 | 69 | |||
| 5% | 29.6% | 21.8% | 26.5% | 16.4% | |||||
| Hay fever | Self | 85 | 4 | 26 | 17 | 23 | 15 | 0.439 | |
| 4.7% | 30.6% | 20% | 27.1% | 17.6% | |||||
| Relatives | 81 | 4 | 32 | 18 | 17 | 10 | |||
| 4.9% | 39.5% | 22.2% | 21% | 12.3% | |||||
| Both | 32 | 2 | 10 | 8 | 7 | 5 | |||
| 6.2% | 31.2% | 25% | 21.9% | 15.6% | |||||
| Neither | 281 | 12 | 85 | 62 | 74 | 45 | |||
| 4.3% | 30.2% | 22.1% | 26.3% | 16% | |||||
| Eczema | Self | 3 | 0 | 1 | 0 | 1 | 1 | 0.250 | |
| 0% | 33.3% | 0% | 33.3% | 33.3% | |||||
| Relatives | 19 | 0 | 11 | 4 | 3 | 1 | |||
| 0% | 57.9% | 21.1% | 15.8% | 5.3% | |||||
| Both | 1 | 0 | 1 | 0 | 0 | 0 | |||
| 0% | 100% | 0% | 0% | 0% | |||||
| Neither | 453 | 22 | 139 | 99 | 117 | 73 | |||
| 4.9% | 30.7% | 21.9% | 25.8% | 16.1% | |||||
**significant at p<0,05
Effect of Sleep Quality on DUECM
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| |||||
| Overall sleep quality | Very good | 201 | 10 | 71 | 42 | 46 | 32 | 0.537 | |
| 5% | 35.3% | 20.9% | 22.9% | 15.9% | |||||
| Fairly good | 171 | 6 | 53 | 38 | 46 | 25 | |||
| 3.5% | 31% | 22.2% | 26.9% | 14.6% | |||||
| Fairly bad | 66 | 3 | 22 | 11 | 19 | 11 | |||
| 4.5% | 33.3% | 16.7% | 28.8% | 16.7% | |||||
| Bad | 16 | 0 | 3 | 6 | 3 | 4 | |||
| 0% | 18.8% | 37.5% | 18.8% | 25% | |||||
| Hours of sleep | Less than 6 | 59 | 4 | 18 | 8 | 18 | 10 | 0.889 | |
| 6.8% | 30.5% | 13.6% | 30.5% | 16.9% | |||||
| 6-7 h | 231 | 13 | 72 | 54 | 53 | 39 | |||
| 5.6% | 31.2% | 23.4% | 22.9% | 169% | |||||
| 8-9 h | 156 | 3 | 55 | 33 | 42 | 21 | |||
| 1.9% | 35.3% | 21.2% | 26.9% | 13.5% | |||||
| More than 9 | 9 | 0 | 3 | 1 | 3 | 2 | |||
| 0% | 33.3% | 11.1% | 33.3% | 22.2% | |||||
| Difficulty falling asleep | Yes | 87 | 3 | 30 | 18 | 21 | 15 | 0.937 | |
| 3.4% | 34.5% | 20.7% | 24.1% | 17.2% | |||||
| No | 363 | 16 | 117 | 78 | 93 | 56 | |||
| 4.4% | 32.2% | 21.5% | 25.6% | 15.4% | |||||
| Difficulty staying asleep | Yes | 84 | 4 | 22 | 17 | 25 | 16 | 0.148 | |
| 4.8% | 26.2% | 20.2% | 29.8% | 19% | |||||
| No | 342 | 16 | 116 | 73 | 80 | 54 | |||
| 4.7% | 33.9% | 21.3% | 23.4% | 15.8% | |||||
| Medication for sleeping problems | Yes | 17 | 0 | 6 | 2 | 6 | 3 | 0.567 | |
| 0% | 35.3% | 11.8% | 35.3% | 17.6% | |||||
| No | 214 | 8 | 69 | 44 | 58 | 32 | |||
| 3.7% | 32.2% | 20.6% | 27.1% | 15% | |||||
| Tiredness in the morning | Yes | 210 | 13 | 68 | 47 | 53 | 28 | 0.155 | |
| 6.2% | 32.4% | 22.4% | 25.2% | 13.3% | |||||
| No | 238 | 7 | 78 | 46 | 61 | 44 | |||
| 2.9% | 32.8% | 19.3% | 25.6% | 18.5% | |||||
| Sleepiness in the evening | Yes | 165 | 7 | 54 | 42 | 45 | 16 | 0.245 | |
| 4.2% | 32.7% | 25.5% | 27.3% | 9.7% | |||||
| No | 282 | 13 | 94 | 50 | 69 | 54 | |||
| 4.6% | 33.3% | 17.7% | 24.5% | 19.1% | |||||
| Sleepiness during the day | Yes | 148 | 7 | 42 | 34 | 43 | 21 | 0.434 | |
| 4.7% | 28.4% | 23% | 29.1% | 14.2% | |||||
| No | 300 | 13 | 107 | 59 | 70 | 49 | |||
| 4.3% | 35.7% | 19.7% | 23.3% | 16.3 | |||||
The red values indicate the "center" of the data (median) **significant at p<0,05
FIGURE 2A-D Spectral imaging values for melanin, oxygenated blood, and dermal scattering taken from under the eye and from the cheek. M = melanin, B = blood volume, S = hemoglobin oxygen saturation and D = dermal scattering factor. The within-subject difference between readings for the under-eye area and the cheek area is indicated by ∆. The volume fraction amounts of melanin (M), the average volume fraction of whole blood (150g Hb/ liter) (B), the oxygen saturation of the blood (S) and the dermal scattering coeffi cient (D) were evaluated